This inventor holds 1 USPTO granted patent. Top assignee: Oriental System Technology Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yun-Hsiang Chen and Microfluidic Electroporation
Introduction
Yun-Hsiang Chen is an inventor based in Taipei, Taiwan, associated with Oriental System Technology Inc. His patent work includes a microfluidic electroporation device designed to improve the speed, cell viability, and collection efficiency of cell transfection.
Latest Patents
Chen is named on 1 patent: “Microfluidic Electroporation Device.” The invention describes a system for introducing exogenous molecules into cells through electroporation in a microfluidic environment. Its components include an electroporation chamber assembly, an adaptor, a pop-up device, a syringe pump assembly, an electroporation controller, and a system controller.
The chamber assembly combines a MEMS nano-channel plate, a MEMS cap, a cell cavity plate, and a holder. The MEMS cap provides inlets and outlets for cell solution, washing solution, transfected cells, and exogenous material solution. A syringe pump assembly moves fluids through plastic tubing and needle adaptors. The pop-up device may use an ultrasound vibrator or a motorized rotator, while the system controller coordinates the operating sequence and can support continuous batch processing.
Career Highlights
Chen’s patent reflects work on integrating microelectromechanical systems, fluid handling, and electroporation into a coordinated device. The design aims to support efficient processing while maintaining cell viability and enabling collection after electroporation.
Collaborations
Chen is associated with Oriental System Technology Inc. His listed coworkers include Chein-Hsun Wang and Jyh-yih Leu.
Conclusion
Yun-Hsiang Chen’s patented microfluidic electroporation system brings together controlled fluid delivery, MEMS components, and automated operation to address key challenges in cell transfection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile